WO2024252336 - PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2024/252336
Publication Date
12.12.2024
International Application No.
PCT/IB2024/055561
International Filing Date
06.06.2024
Title **
[English]
PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF
[French]
COMPOSITIONS PEPTIDIQUES CIBLANT LE GLYPICANE-3 ET LEURS UTILISATIONS
Applicants **
PEPTIDREAM INC.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
Inventors
EHARA, Takeru
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
KOMURA, Rie
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
MIZUKOSHI, Yoshihide
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
MORIMOTO, Kouki
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
TAKUWA, Masatoshi
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
YANAGIDA, Hayato
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
OHUCHI, Masaki
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
NAGASAWA, Takayuki
c/o PeptiDream Inc.
3-25-23 Tonomachi
Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-0821, JP
Priority Data
63/506,651
07.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 5467 | |
| EPO | Filing, Examination | 72118 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 25835 |
Total: 104589 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present technology generally relates to peptides that bind to phosphatidylinositol proteoglycan 3 (GPC3), to peptides that bind to the GPC3, and to compositions comprising such peptides.[French]
La présente technologie concerne de manière générale des peptides qui se lient au phosphatidylinositol protéoglycane 3 (GPC3), des peptides qui se lient au GPC3, ainsi que des compositions comprenant de tels peptides.